17 Aug Fluoropyrimidine containing medicines and related substances: Increased drug exposure and toxicity in patients with dihydropyrimidine dehydrogenase (DPD) deficiency
Posted at 12:38h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), the companies listed below would like to inform you of the requirement of pre-testing to identify patients at increased risk of severe toxicity due to fluoropyrimidine containing medicines.
2020 Oct
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
22/10/2020
File Type:
pdf
Category:
Communication To Health Care Professionals